Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FWSTN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for VYNDAMAX 61 mg capsule unit dose packs (30 count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex pharmaceutical supply requirements across multiple therapeutic domains. VYNDAMAX (tafamidis), a specialty medication used in the treatment of transthyretin amyloidosis, reflects the sophisticated nature of pharmaceuticals supplied through the DLA Troop Support Medical contract vehicle. The DLA plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the key vendors supporting Defense Health Agency and other government healthcare systems globally.
Quick answers
Who was awarded contract SPE2DB25FWSTN?
SPE2DB25FWSTN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FWSTN worth?
The government has obligated $13,847 on SPE2DB25FWSTN.
Is contract SPE2DB25FWSTN an order under another contract?
Yes. SPE2DB25FWSTN is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWSTN competed?
The extent of competition for SPE2DB25FWSTN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award